MedTrace Logo

MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay

NCT04659746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2022-01-27

No results posted yet for this study

Summary

MejoraCare-Paraguay main objective is to test a mHealth solution (MejoraCare app) to be used for the education and empowerment of chronic patients (COPD, cancer, diabetes, heart disease. hypertension, etc.), and for supporting healthcare professionals to monitor and better understand patients' evolution during the COVID-19 outbreak (MejoraCare dashboard).

This mHealth solution is built upon the Adhera platform, which has already been validated in other therapeutic areas such as smoking cessation.

MejoraCare is expected to raise awareness, educate and empower chronic patients, promoting behavioral changes towards adhering to healthier lifestyles thus reducing the risk of COVID-19 infection while providing emotional regulation support aiming at improving their mental health, quality of life, and emotional well-being.

Conditions

  • Quality of Life
  • Stress
  • Emotional Adjustment

Interventions

DEVICE

MejoraCare

mHealth solution to support remote monitoring of symptoms and patient empowerment through education.

Sponsors & Collaborators

  • Adhera Health, Inc.

    collaborator INDUSTRY

  • University of Valencia

    collaborator OTHER

  • Universidad Autónoma de Encarnación

    lead OTHER

Principal Investigators

  • Rosa María Baños, PhD · Universitat de València-Estudi General

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-09
Primary Completion
2021-02-28
Completion
2021-12-09

Countries

  • Paraguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04659746 on ClinicalTrials.gov